Literature DB >> 28749252

The role of Dickkopf-1 as a potential prognostic marker in pancreatic ductal adenocarcinoma.

De-Jun Liu1, Yue-Xia Xie2, Xiao-Xing Liu3, Yan-Miao Huo1, Min-Wei Yang1, Xue-Liang Fu1, Wei Liu1, Jian-Yu Yang1, Jiao Li1, Rong Hua1, Pei-Feng Liu2, Yong-Wei Sun1, Jun-Feng Zhang1.   

Abstract

Dickkopf-1(DKK-1), the downstream target of β-catenin/T-cell factor, participates in a negative feedback loop in the Wnt signaling and reported as an important biomarker in many tumors. In this study, we analyzed the expression of DKK-1 in pancreatic ductal adenocarcinoma (PDAC) patients at both mRNA and protein levels. We used real-time PCR to detect the expression of DKK-1 in 32 PDAC and paired adjacent non-tumor tissues, results suggested that the expression of DKK-1 was increased in PDAC tissues. We found the similar results in the analysis of 3 independent microarray data sets. Immunohistochemical staining of 311 pairs of PDAC tissues suggested that DKK-1 expression was significantly associated with T classification (P = 0.039) and lymph node metastasis (P = 0.035). Furthermore, Kaplan-Meier analysis for DKK-1 expression demonstrated that patients with higher DKK-1 level had shorter overall survival (OS) and relapse-free survival (RFS) time in Ren Ji cohort and online PDAC database at both mRNA and protein levels. Univariable and multivariable Cox regression analysis confirmed that DKK-1 as well as lymph node metastasis and histology were independent predictors of OS in patients with PDAC. This study demonstrated that DKK-1 may be a predictor for prognosis in PDAC patients.

Entities:  

Keywords:  Biomarker; DKK-1; Pancreatic cancer; Pancreatic ductal adenocarcinoma; Prognosis; Tissue microarray; Wnt signaling

Mesh:

Substances:

Year:  2017        PMID: 28749252      PMCID: PMC5587096          DOI: 10.1080/15384101.2017.1356510

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  22 in total

1.  DKK1, a negative regulator of Wnt signaling, is a target of the beta-catenin/TCF pathway.

Authors:  Atsushi Niida; Takatoshi Hiroko; Mana Kasai; Yoichi Furukawa; Yusuke Nakamura; Yutaka Suzuki; Sumio Sugano; Tetsu Akiyama
Journal:  Oncogene       Date:  2004-11-04       Impact factor: 9.867

Review 2.  Developments in metastatic pancreatic cancer: is gemcitabine still the standard?

Authors:  Jie-Er Ying; Li-Ming Zhu; Bi-Xia Liu
Journal:  World J Gastroenterol       Date:  2012-02-28       Impact factor: 5.742

Review 3.  The WNT signaling pathway from ligand secretion to gene transcription: molecular mechanisms and pharmacological targets.

Authors:  Hoeke A Baarsma; Melanie Königshoff; Reinoud Gosens
Journal:  Pharmacol Ther       Date:  2013-01-14       Impact factor: 12.310

4.  Cell biology. Making a point with Wnt signals.

Authors:  J D Berndt; R T Moon
Journal:  Science       Date:  2013-03-22       Impact factor: 47.728

5.  Functional and structural diversity of the human Dickkopf gene family.

Authors:  V E Krupnik; J D Sharp; C Jiang; K Robison; T W Chickering; L Amaravadi; D E Brown; D Guyot; G Mays; K Leiby; B Chang; T Duong; A D Goodearl; D P Gearing; S Y Sokol; S A McCarthy
Journal:  Gene       Date:  1999-10-01       Impact factor: 3.688

6.  Activation of the Wnt pathway through Wnt2 promotes metastasis in pancreatic cancer.

Authors:  Hua Jiang; Qingqing Li; Chengzhi He; Fengru Li; Haihui Sheng; Xiaoying Shen; Xiaoyan Zhang; Shizhang Zhu; Hui Chen; Ximei Chen; Changqing Yang; Hengjun Gao
Journal:  Am J Cancer Res       Date:  2014-09-06       Impact factor: 6.166

7.  Dickkopf-1 is a member of a new family of secreted proteins and functions in head induction.

Authors:  A Glinka; W Wu; H Delius; A P Monaghan; C Blumenstock; C Niehrs
Journal:  Nature       Date:  1998-01-22       Impact factor: 49.962

8.  Dickkopf-1 is overexpressed in human pancreatic ductal adenocarcinoma cells and is involved in invasive growth.

Authors:  Nobuyasu Takahashi; Tsuyoshi Fukushima; Kenji Yorita; Hiroyuki Tanaka; Kazuo Chijiiwa; Hiroaki Kataoka
Journal:  Int J Cancer       Date:  2010-04-01       Impact factor: 7.396

9.  Dikkopf-1 as a novel serologic and prognostic biomarker for lung and esophageal carcinomas.

Authors:  Takumi Yamabuki; Atsushi Takano; Satoshi Hayama; Nobuhisa Ishikawa; Tatsuya Kato; Masaki Miyamoto; Tomoo Ito; Hiroyuki Ito; Yohei Miyagi; Haruhiko Nakayama; Masahiro Fujita; Masao Hosokawa; Eiju Tsuchiya; Nobuoki Kohno; Satoshi Kondo; Yusuke Nakamura; Yataro Daigo
Journal:  Cancer Res       Date:  2007-03-15       Impact factor: 12.701

10.  Serum dickkopf-1 is a novel serological biomarker for the diagnosis and prognosis of pancreatic cancer.

Authors:  Su-xia Han; Xia Zhou; Xin Sui; Chen-chen He; Meng-jiao Cai; Jin-lu Ma; Yuan-yuan Zhang; Cong-ya Zhou; Chen-xian Ma; Armando Varela-Ramirez; Qing Zhu
Journal:  Oncotarget       Date:  2015-08-14
View more
  8 in total

Review 1.  Dickkopf1: An immunomodulatory ligand and Wnt antagonist in pathological inflammation.

Authors:  Wook-Jin Chae; Alfred L M Bothwell
Journal:  Differentiation       Date:  2019-06-12       Impact factor: 3.880

Review 2.  The Clinical Diagnostic and Prognostic Value of Dickkopf-1 in Cancer.

Authors:  Jie Li; Yan Gao; Wentao Yue
Journal:  Cancer Manag Res       Date:  2020-06-08       Impact factor: 3.989

3.  A novel messenger RNA signature as a prognostic biomarker for predicting relapse in pancreatic ductal adenocarcinoma.

Authors:  Guodong Shi; Jingjing Zhang; Zipeng Lu; Dongfang Liu; Yang Wu; Pengfei Wu; Jie Yin; Hao Yuan; Qicong Zhu; Lei Chen; Yue Fu; Yunpeng Peng; Yan Wang; Kuirong Jiang; Yi Miao
Journal:  Oncotarget       Date:  2017-12-02

4.  Dickkopf-related protein 1, a new biomarker for local immune status and poor prognosis among patients with colorectal liver Oligometastases: a retrospective study.

Authors:  Qiaoqi Sui; Jian Zheng; Dingxin Liu; Jianhong Peng; Qingjian Ou; Jinghua Tang; Yuan Li; Lingheng Kong; Wu Jiang; Binyi Xiao; Xue Chao; Zhizhong Pan; Huizhong Zhang; Pei-Rong Ding
Journal:  BMC Cancer       Date:  2019-12-12       Impact factor: 4.430

Review 5.  Diagnosis Accuracy and Prognostic Significance of the Dickkopf-1 Protein in Gastrointestinal Carcinomas: Systematic Review and Network Meta-analysis.

Authors:  Xiaowen Jiang; Fuhai Hui; Xiaochun Qin; Yuting Wu; Haihan Liu; Jing Gao; Xiang Li; Yali Xu; Yingshi Zhang
Journal:  J Cancer       Date:  2020-10-18       Impact factor: 4.207

6.  Investigation of the Antitumor Effects of Tamoxifen and Its Ferrocene-Linked Derivatives on Pancreatic and Breast Cancer Cell Lines.

Authors:  Márton Kalabay; Zsófia Szász; Orsolya Láng; Eszter Lajkó; Éva Pállinger; Cintia Duró; Tamás Jernei; Antal Csámpai; Angéla Takács; László Kőhidai
Journal:  Pharmaceuticals (Basel)       Date:  2022-03-05

7.  Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer.

Authors:  Bo Liu; Tingting Fu; Ping He; Chengyou Du; Ke Xu
Journal:  Biosci Rep       Date:  2021-07-30       Impact factor: 3.840

8.  Prognostic role of dickkopf-1 in patients with cancer.

Authors:  Junfang Huang; Tao Lu; Wenbing Kuang
Journal:  Medicine (Baltimore)       Date:  2020-05-22       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.